Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Myofibroblasts produce the fibrous scar in hepatic fibrosis. In the carbon tetrachloride (CCl(4)) model of liver fibrosis, quiescent hepatic stellate cells (HSC) are activated to become myofibroblasts. When the underlying etiological agent is removed, clinical and experimental fibrosis undergoes a remarkable regression with complete disappearance of these myofibroblasts. Although some myofibroblasts apoptose, it is unknown whether other myofibroblasts may revert to an inactive phenotype during regression of fibrosis. We elucidated the fate of HSCs/myofibroblasts during recovery from CCl(4)- and alcohol-induced liver fibrosis using Cre-LoxP-based genetic labeling of myofibroblasts. Here we demonstrate that half of the myofibroblasts escape apoptosis during regression of liver fibrosis, down-regulate fibrogenic genes, and acquire a phenotype similar to, but distinct from, quiescent HSCs in their ability to more rapidly reactivate into myofibroblasts in response to fibrogenic stimuli and strongly contribute to liver fibrosis. Inactivation of HSCs was associated with up-regulation of the anti-apoptotic genes Hspa1a/b, which participate in the survival of HSCs in culture and in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, restored RSPO3 expression during HSC deactivation52,53 or by therapeutic interventions might help to regain hepatocyte functions.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [52]
In the citing paper
“Animal models reinforce the capacity of the injured liver to regress fibrosis and provide important platform for dissecting underlying mechanisms, although it should be noted that fibrosis in mice regresses incredibly rapidly, which may be in part attributed to the short duration of models (weeks to months in mice vs. years to decades in humans) and initiation of fibrosis at relatively young age (”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [262]
In the citing paper
“Fibroblast activation also involves increased activity of key glycolytic enzymes, such as hexokinase 2 and lactate dehydrogenase (LDH)47, which in turn increase cell proliferation47 and collagen synthesis48.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
In the citing paper
“During enhanced glycolysis, increased amounts of pyruvate are converted to acetyl-CoA in the mitochondrial matrix47 before entering the citric acid cycle. This yields intermediate metabolites, such as succinate, which promote fibrosis49.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Self-citationBataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 8×
“Myofibroblasts are aSMA collagen type I cells that are absent from the normal uninjured liver, rapidly emerge infibrotic liver to produce thefibrous scar, and completely disappear with regression of liver fibrosis (1, 2).”
BackgroundInfluentialThe role of matrix stiffness in regulating cell behavior†
Wells, R. G. (2008) · Hepatology · doi:10.1002/hep.22193 · Cited by 1,059
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Lee, K. S., Buck, M., Houglum, K., & Chojkier, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118304 · Cited by 539
Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., & Kaufmann, S. H. E. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.011 · Cited by 410
Lee, C. G., Cho, S. J., Kang, M. J., Chapoval, S. P., Lee, P. J., Noble, P. W., Yehualaeshet, T., Lu, B., Flavell, R. A., Milbrandt, J., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040104 · Cited by 369
Cited by
Items 701–800 of 889
Circadian clock regulation of myofibroblast fate
Tsoneva, Y., Velikova, T. V., & Nikolaev, G. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111774 · Cited by 1
Yu, C., Liao, H.-Y., Yeh, J., Wang, S., Lu, M., Liao, Y., Yu, C., & Lin, F.-C. (2025) · Journal of Dental Sciences · doi:10.1016/j.jds.2025.04.008 · Cited by 1
Hepatic stellate cell-derived Delta-like 1 is dispensable for injury-induced liver fibrosis
Chen, C., Zhang, M., Ma, X., Wang, C.-M., Shi, Y., Yuan, J., & Zhang, W. J. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152011 · Cited by 1
Насрединович, М. С., Мехтиева, О. А., Михайловна, Б. О., & Lovitskiy, A. S. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-352 · Cited by 1
Martínez, E. M., Juárez‐Mercado, A. P., González‐Gallardo, A., Núñez-Ríos, J. D., Díaz‐Muñoz, M., Hernández-Muñoz, R. E., & Vázquez‐Cuevas, F. G. (2025) · Cells · doi:10.3390/cells14231845 · Cited by 1
Abdelnabi, M. N., Maali, Y., Dabbaghizadeh, A., Mokariasl, N., Dion, J., Yamak, R., Soucy, G., Hassan, G. S., & Shoukry, N. H. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf332 · Cited by 1
Kim, K., Taleb, S., So, J., Wann, J., & Roh, H. C. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.100917 · Cited by 1
Shen, X., Deng, J., Jiang, A., Cai, Q., Tian, D., Zhao, L., Ye, J., Zhang, L., Xiang, Y., & Zhang, Q. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2686514 · Cited by 1
Liu, X., Hou, M., Wei, W., Mao, R., Wang, X., Qiu, H., Lv, H., Wang, C., & Gao, J.-F. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c01083 · Cited by 1
Yang, X., Steffani, M., Nadella, S., Sheppard, D., Rieder, F., Rinkevich, Y., Kramann, R., Tuveson, D. A., & Schwabe, R. F. (2026) · JCI Insight · doi:10.1172/jci.insight.202529 · Cited by 1
Pentoxifylline attenuates hepatic fibrosis by inhibiting hepatic stellate cells
Abdel‐Hamid, A. A. M., & Ali, E. (2015) · The Egyptian Journal of Histology · doi:10.1097/01.ehx.0000464787.34981.cc · Cited by 1
Masoud, M. A. A., Kasem, M. A., El-Sharwy, A. F., El-Sebaey, A. F., & Abdalrhman, T. I. (2020) · Al-Azhar Medical Journal · doi:10.21608/amj.2020.67553 · Cited by 1
[Reversal of hepatic fibrosis: more evidence and more challenges].
Zhang, J., Sun, Y., Chen, S. Y., & You, H. (2022) · PubMed Central · doi:10.3760/cma.j.cn501113-20220510-00255 · Cited by 1
[Reversal mechanism of hepatic fibrosis].
Qi, J., Hu, X., & Ch, L. (2022) · PubMed Central · doi:10.3760/cma.j.cn501113-20220504-00239 · Cited by 1
Ghufran, S. M., Sharma, S. K., Ghose, S., & Biswas, S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08210-6 · Cited by 1
Wislet‐Gendebien, S. (2014) · InTech eBooks · doi:10.5772/57290 · Cited by 1
Kikuchi, A. (2017) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
The Liver's Response to Injury
Cong, M., Jia, J., Kisseleva, T., & Brenner, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00005-7 · Cited by 1
Self-citationGee, L., & Oakley, F. (2021) · The Receptors · doi:10.1007/978-3-030-55920-5_14 · Cited by 1
Friedman, S. L. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch10 · Cited by 1
Down-regulation of hepatic MBOAT7 by hyperinsulinemia favors steatosis development
Meroni, M., Dongiovanni, P., Longo, M., Rametta, R., Badiali, S., Fargion, S., Romeo, S., Gatti, S., & Valenti, L. V. C. (2018) · Journal of Hepatology · doi:10.1016/s0168-8278(18)30280-0 · Cited by 1
Hepatic Stellate Cell Depletion and Genetic Manipulation
Sun, Q., & Schwabe, R. F. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3207-9_12 · Cited by 1
« A star is reborn »: Nouvelles avancées sur les fonctions de la cellule étoilée du foie
Gilgenkrantz, H. (2023) · médecine/sciences · doi:10.1051/medsci/2023168 · Cited by 1
Erdoğan, M. A. (2024) · Düzce Tıp Fakültesi Dergisi · doi:10.18678/dtfd.1496879 · Cited by 1
Zhang, Y., Kadiyala, P., Yan, W., Brown, K. L., Avritt, F. R., Donahue, K. L., Procario, M. C., Okoye, J. O., Giridharan, T., Elhossiny, A. M., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-1300 · Cited by 1
Tanikawa, A. A. (2015) · Americanae (AECID Library) · Cited by 2
IDENTIFICATION AND ELUCIDATION OF MIR-214 AND MIR-29A AS POTENT REGULATORS OF LIVER FIBROSIS
Knabel, M. K. (2013) · Cited by 1
Hereditary angioedema: modification of clinical manifestations with androgens.
Davis, P. J., Davis, F. B., & Charache, P. (1976) · PubMed · Cited by 1
Zoubek, M. E. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210929mz · Cited by 1
Lung injury epigenetically primes mesenchyme for amplified activation upon re-injuryPreprint
Jones, D. L., Caporarello, N., Meridew, J. A., Choi, K. M., Haak, A. J., Link, P. A., Tan, Q., Ördög, T., Ligresti, G., & Tschumperlin, D. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.04.483065 · Cited by 1
Karsdal, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817068-7.02001-2 · Cited by 1
Wang, J., Tao, J., Xia, C., Tang, M., Stoica, A.-F., Yuan, S., Li, Y., Guo, L., Kong, X., & Wang, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.25.690307 · Cited by 1
Lee, N. S., Datta, P., Huang, Y., Raykowski, B., Yu, X., Guo, T., He, P., Moolayadukkam, S., Tew, B. Y., Xiong, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.15.718753 · Cited by 1
Stone, L. C. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
King, A. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
Liver cell types derived from pluripotent stem cells
Harrison, S. P. (2014) · Research Explorer (The University of Manchester)
Abdelall, G. M. (2015) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6750
The role of stromal cells in Hepatitis C virus infection
Galsinh, S. K. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Duffield, J. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800102-8.00023-0
Regulación de la fibrogénesis hepática por la UPR y la proteína COMP
Ruiz-de-Galarreta-Martínez, M. (2015) · Depósito Académico Digital Universidad de Navarra (University of Navarra)
1) Reversibility and Treatment of Liver Fibrosis
Inagaki, Y., & Sumiyoshi, H. (2014) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.103.104a
Animal Models of Alcoholic Liver Disease
Xu, J., & Tsukamoto, H. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_5
Self-citationOstanin, A. A., Михайловна, С. Н., Меледина, И. В., Shipunov, M. V., Leplina, O. Y., Shevela, Е. Y., & Chernykh, E. R. (2016) · Medical Immunology (Russia) · doi:10.15789/1563-0625-2016-1-63-78
Functional and diagnostic role of microRNAs in Schistosoma mansoni infection
Hoy, A. M. (2015) · ERA
Morphogen and epigenetic regulation of wound healing
Corbett, L. (2015)
1) Reversibility and Treatment of Liver Fibrosis
Inagaki, Y., & Sumiyoshi, H. (2014) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.103.2171
Liver regeneration and cellular adaptation to chronic diseases: a systems biology investigation
COOK, D. J. (2016) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/xprf-br39
The Role of Intercellular Contacts in EpithelialL-mesenchymal/-myofibroblast Transition
Charbonney, E. (2013) · TSpace (University of Toronto)
Expression of α-Smooth Muscle Actin Regulates the Function Of Mesenchymal Stromal Cells
Talele, N. P. (2015) · TSpace (University of Toronto)
Relaxin as a therapeutic haemodynamic modulator in liver disease
Snowdon, V. (2016) · ERA
Anti-fibrotic activity of medicinal plants
Akhtar, U., & Ahmad, M. (2017) · Bangladesh Journal of Pharmacology · doi:10.3329/bjp.v12i4.32947
Investigation of the role of hepatic stellate cells in acute liver failure and hepatocarcinogenesis
Thompson, A. (2017) · ERA
Elhessy, H. M., Hazem, N. M., Saleh, D. M., & Botros, K. G. (2018) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2018.8110
WITHDRAWN: Rodent models of fatty liver diseases
Bertola, A. (2018) · Liver Research · doi:10.1016/j.livres.2018.02.005
RetractedComprehensive Evaluation of the Anti-fibrogenic Effect of Astaxanthin in Hepatic Stellate Cells
Bae, M. (2018) · OpenCommons - UConn (University of Connecticut)
Copple, B. L., & Roth, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64336-2
Post-translational modifications in liver disease
Zubiete‐Franco, I. (2017) · Communities in ADDI (Universidad del Pais Vasco)
Fibroblast activation and pro-fibrotic phenotypes: modulation by FGF2 and MAPK signaling
Dolivo, D. (2018) · Digital WPI
Identification and characterisation of the restorative hepatic macrophage
Ramachandran, P. (2014) · ERA
Antifibrotic Therapy for Liver Cirrhosis
Thủy, L. T. T., Hai, H., Hieu, V. N., Dat, N. Q., Hoang, D. V., & Kawada, N. (2019) · Springer eBooks · doi:10.1007/978-981-13-7979-6_15
Guixé‐Muntet, S. (2017) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
BH3 Mimetic Drugs for Anti-fibrotic Therapy
Lagares, D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00235
Spatiotemporal regulation of anti-remodelling signalling pathways in primary human lung fibroblasts
Roberts, M. J. (2020) · Nottingham ePrints (University of Nottingham) · doi:10.26180/12021315
Vetter, D., & Friedman, S. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00007-8
Septiana, W. L., Antarianto, R. D., Louisa, M., Jusuf, A. A., Barasila, A. C., Pawitan, J. A., & Fasha, I. (2020) · Makara Journal of Health Research · doi:10.7454/msk.v24i2.1200
FGF21이 간 성상세포의 미토콘드리아 활성에 미치는 영향
장수희 (2014) · Seoul National University Open Repository (Seoul National University)
Modèle de fibrogenèse hépatique humaine : analyses immunopathologiques
Kartasheva-Ebertz, D. (2020) · theses.fr (ABES) · doi:10.70675/70f5a21azd6bbz487ez8d05zc9deb14b890b
Identificación de dianas terapéuticas en fibrosis hepática y cáncer
Tutusaus, A. (2018) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Targeting hepatic stellate cells to prevent or reverse liver fibrosis
Zhang, M. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.146692010
Proceeding of the Ronald G. Thurman Memorial Symposium 2020
Arteel, G. E., Kisseleva, T., Akazawa, Y., Yamashina, S., Tsukamoto, H., Beier, J. I., Hikita, H., Iwaisako, K., Iimuro, Y., Brenner, D. A., et al. (2021) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.jmj21-p04
Self-citationMesenchymal stromal cell therapy for liver fibrosis
Haldar, D. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
SPOCK1: New Mechanistic Insight into Liver Fibrosis
Du, Z., Fan, Y., & Tian, D. (2021) · Journal of Cellular Signaling · doi:10.33696/signaling.2.046
KLF4 Inhibits Activation of Human Hepatic Stellate Cells LX-2 in vitroPreprint
Xue, Y., Tan, J., Yao, T., Chen, Q., Jiang, K., Wang, Z., & Zheng, H. (2021) · Research Square · doi:10.21203/rs.3.rs-702048/v1
Òdena, G., Stein, E. J., & Bataller, R. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-13614-1_8
Labour performance and costs of harvesting system revealed on witloof chicory farms.
Geven, C. G. M. (2000)
Hordijk, P. L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727869540.793546218
Gabbiani, G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736937977.793567771
Vignjevic, D. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732530972.793549336
Molecular Basis of Liver Disease
Monga, S. P., & Behari, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00020-1
Faculty Opinions recommendation of Matrix and cell phenotype differences in Dupuytren's disease.
Nanchahal, J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727006221.793556761
Role of Circulating Hematopoietic Fibrocytes in Chronic Hepatitis C Patients Induced Liver Fibrosis
El-Bassiouni, N. E., Amin, N. A., Rizk, S., Azayem, M. K. A. E., Madkour, M., Garem, H., Ibrahim, R., & Nil, O. B. A. E. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.8123
Cells, cytokines, and factors involved in profibrogenic pathways
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00014-7
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00010-x
Anthony, M. J. A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188913
Repeated toxic injuries of murine liver are tolerated through minute steatosis and mild inflammation
Hammad, S., Ogris, C., Othman, A., Erdoesi, P., Schmidt‐Heck, W., Biermayer, I., Helm, B., Gao, Y., Piorońska, W., D’Alessandro, L. A., et al. (2023) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0042-1759925
Di, Y., Jiang, Y., Zhi, F., Hu, Y. C., Xu, R., Liu, J., Zhao, L., Ning, D., & Jin, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2832582/v1
Efficacy of homeopathic medicine in treatment of teat fibrosis and mastitis in cows
Chakraborty, P., Islam, S. A., Imtiaz, M. A., Mazumder, A. K., & Saifuddin, A. (2020) · doi:10.60015/bjvas/v08i1a4
Examination of cancer cells and their ambient matrix using NMR and MRE
Mierke, C. T. (2023) · Institute of Physics eBooks · doi:10.1088/978-0-7503-6274-0ch1
Drasdo, D., Zhao, J., Hammad, S., de Langlard, M., Erdoesi, P., Li, Y., Liedekerke, P. V., Buttenschön, A., Winkler, M., Kürschner, S. W., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3911195/v1
Karsdal, M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15617-5.02001-1
Zhang, Y., Liu, X., Wang, Y., Liu, M., Guo, Z., Zhang, J., Wu, F., & Chen, G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.27.577553
Stem Cells and Extracellular Vesicles for Prevention and Treatment of Liver Fibrosis
Sulaiman, S. A., Adrus, M. N. H., Dorairaj, V., Abu, N., Mutalib, N. A., Nawawi, K. N. M., & Murad, N. A. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00066-4
O-GlcNAcylation : how does O-GlcNAc transferase regulate liver physiology ?
Ortega-Prieto, P. (2020) · theses.fr (ABES) · doi:10.70675/5d8da13dz99e5z4145zb1fbz0d37c02b28ac
Metadata
- Authors
- Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., Evans, S. M., Dillmann, W., Glass, C. K., & Brenner, D. A.
- Affiliations
- Department of Medicine,
- Universitätsklinikum Aachen (DE)
- Department of Cellular and Molecular Medicine,
- School of Pharmacy, University of California, San Diego, CA 92093;
- University of Southern California (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-05-07
- Volume
- 109
- Issue
- 24
- Pages
- 9448-9453
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3386114
- OpenAlex
- W2075290880
- Cited by
- 805
- References
- 27
- Citations by year
- 2026: 29 · 2025: 51 · 2024: 61 · 2023: 59 · 2022: 53 · 2021: 62 · 2020: 64 · 2019: 52 · 2018: 53 · 2017: 61 · 2016: 64 · 2015: 73 · 2014: 63 · 2013: 42 · 2012: 13
- FWCI
- 38.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM041804)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- myofibroblasts, hepatic stellate cells, liver fibrosis, fibrosis regression, apoptosis, anti-apoptotic genes, carbon tetrachloride, alcohol-induced liver injury, fibrogenic gene expression
- MeSH terms
- Animals, Liver Cirrhosis, Phenotype, Tamoxifen, Adoptive Transfer, Collagen Type I, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.